These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18473864)

  • 1. Anticoagulation in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary angiography and interventions.
    Joost A; Kurowski V; Radke PW
    Curr Pharm Des; 2008; 14(12):1176-85. PubMed ID: 18473864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
    Matthai WH
    Semin Thromb Hemost; 1999; 25 Suppl 1():57-60. PubMed ID: 10357153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation strategies for patients undergoing percutaneous coronary intervention: unfractionated heparin, low-molecular-weight heparins, and direct thrombin inhibitors.
    Kokolis S; Cavusoglu E; Clark LT; Marmur JD
    Prog Cardiovasc Dis; 2004; 46(6):506-23. PubMed ID: 15224257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Mahaffey KW
    Curr Cardiol Rep; 2001 Sep; 3(5):362-70. PubMed ID: 11504572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Hursting MJ
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
    Dhillon S
    Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass grafting.
    Becker RC
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():59-68. PubMed ID: 11155195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious acute coronary thrombosis associated with heparin-induced thrombocytopenia in off-pump coronary artery bypass grafting.
    Matsue H; Masai T; Yoshikawa Y; Kawamura M
    Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):188-90. PubMed ID: 20504888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin induced thrombocytopenia.
    Gupta S; Gupta MM
    J Assoc Physicians India; 2008 Aug; 56():622-7. PubMed ID: 19051709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Matthai WH; Cohen M; Moses JW; Hursting MJ; Leya F;
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):177-84. PubMed ID: 12357516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Iaffaldano R; McKiernan TL; Rao L; Donkin J; Wallenga JM
    Cathet Cardiovasc Diagn; 1996 Jun; 38(2):206-9. PubMed ID: 8776531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalirudin.
    Warkentin TE; Greinacher A; Koster A
    Thromb Haemost; 2008 May; 99(5):830-9. PubMed ID: 18449412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute left main occlusion during percutaneous coronary intervention associated with heparin induced thrombocytopenia with thrombosis syndrome.
    Ziakas A; Gavrilidis S; Makris P; Louridas G
    J Interv Cardiol; 2005 Apr; 18(2):139-44. PubMed ID: 15882162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia.
    Nikolsky E; Dangas GD
    Semin Thromb Hemost; 2004 Jun; 30(3):305-14. PubMed ID: 15282653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia (HIT) causing pulmonary emboli during coronary intervention.
    Jiji RS; Michaels AD
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):819-22. PubMed ID: 18798244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A guide to drug use during percutaneous coronary intervention.
    Choo JK; Young JJ; Kereiakes DJ
    Drugs; 2002; 62(18):2589-601. PubMed ID: 12465999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy.
    Walenga JM; Bick RL
    Med Clin North Am; 1998 May; 82(3):635-58. PubMed ID: 9646784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.